Abstract
Roux-en-Y gastric bypass is the most commonly performed bariatric operation in the USA. Anastomotic leak is one of the devastating complications in this operation. By using fibrin sealant around the anastomosis, surgeons can achieve better hemostasis around the suture-line and prevent or decrease the incidence of anastomotic leaks. This paper discusses the biological and clinical evidence for use of fibrin sealant in laparoscopic gastric bypass.
MeSH terms
-
Anastomosis, Roux-en-Y / adverse effects
-
Anastomosis, Roux-en-Y / methods
-
Animals
-
Disease Models, Animal
-
Female
-
Fibrin Tissue Adhesive / therapeutic use*
-
Follow-Up Studies
-
Gastric Bypass / adverse effects
-
Gastric Bypass / methods*
-
Gastrointestinal Hemorrhage / prevention & control
-
Gastroscopy / methods
-
Humans
-
Laparoscopy / adverse effects
-
Laparoscopy / methods*
-
Male
-
Obesity, Morbid / diagnosis
-
Obesity, Morbid / surgery*
-
Prospective Studies
-
Risk Assessment
-
Sensitivity and Specificity
-
Sus scrofa
-
Tensile Strength
-
Treatment Outcome